The Role of Consolidative Autologous Stem Cell Transplantation After First-line Therapy in Peripheral T Cell Lymphoma

Inclusion Criteria: * Patients with confirmed pathological diagnosis of aggressive PTCL * Age 18-65 years old * Achieving CR or PR after first-line therapy Exclusion Criteria: * Subtypes with a more indolent course, including precursor T/natural killer neoplasms, T-cell large granular lymphocytic leukemia, mycosis fungoides other than transformed mycosis fungoides, Sézary syndrome, and primary cutaneous CD30-positive disorders.